Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as $6.52 and last traded at $6.53, with a volume of 2079355 shares. The stock had previously closed at $6.86.
Analysts Set New Price Targets
Separately, Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a report on Wednesday, January 28th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold”.
Check Out Our Latest Research Report on Coloplast A/S
Coloplast A/S Stock Down 4.8%
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last announced its earnings results on Friday, February 6th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%.The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.12 billion. Equities research analysts anticipate that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current year.
Coloplast A/S Company Profile
Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.
In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.
Featured Articles
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
